UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_________________

FORM 8-K

_________________

CURRENT REPORT

Pursuant to Section 13 or 15(d)of the Securities Exchange Act of 1934

Date of ~~the~~Report ~~Securities~~(Date ~~Exchange~~of ~~Act~~earliest ofevent ~~1934~~reported): October 30, 2025

Date of Report (Date of earliest event reported): September 9, 2025

_______________________________

~~ALIGNMENT~~Alignment ~~HEALTHCARE~~Healthcare, ~~INC~~Inc.

(Exact name of registrant as specified in its charter)

_______________________________

Delaware	001-40295	46-5596242
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)

1100 W. Town and Country Road, Suite 1600

Orange, California 92868

(Address of Principal Executive Offices) (Zip Code)

(844) 310-2247

(Registrant's telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

_______________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) o☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) o☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) o☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.001 per share	ALHC	The NASDAQ Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company o☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o☐

Item 72.~~01 Regulation~~02. FDResults ~~Disclosure~~of Operations and Financial Condition.

~~Senior~~On ~~leaders~~October ~~from~~30, 2025, Alignment Healthcare, Inc. ~~(the~~issued ~~"Company")~~a ~~are~~press ~~meeting~~release ~~with~~announcing ~~investors~~its ~~and~~financial ~~analysts~~results ~~between~~for ~~September~~its 9,third ~~2025~~quarter ~~and~~ended September 1030, 2025~~, during which the Company intends to discuss its strategy, market position and recent results~~. ~~The~~ ~~Company~~A ~~will~~copy ~~also~~of ~~discuss preliminary Centers for Medicare & Medicaid Services (CMS) Medicare Advantage Star ratings for rating year 2026 / payment year 2027. While~~ the ~~related~~press ~~data~~release is ~~still~~furnished ~~under~~herewith ~~evaluation,~~as ~~based~~Exhibit on99.1 aand ~~preliminary~~incorporated ~~review,~~herein ~~the~~by ~~Company will reaffirm its expectation that approximately 100% of its membership will be in 4 Star or higher plans~~reference.

~~Cautionary~~The ~~Statement~~information contained in this Current Report on Form 8-K and in the accompanying exhibit are “furnished” and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference in such filing.

~~This~~Item Current Report on Form 8-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and the Private Securities Litigation Reform Act of 1995, as amended9. Forward-looking statements are subject to risks and uncertainties and are based on assumptions that may prove to be inaccurate, which could cause actual results to differ materially from those expected or implied by the forward-looking statements01. ~~Actual~~Financial ~~results~~Statements ~~may differ materially from the results predicted,~~ and ~~reported results should not be considered as an indication of future performance~~Exhibits. Important risks and uncertainties that could cause the Company’s actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: the Company's ability to attract new members and enter new markets, including the need for certain governmental approvals; its ability to maintain a high rating for its plans on the Five Star Quality Rating System; its ability to develop and maintain satisfactory relationships with care providers that service its members; risks associated with being a government contractor; changes in laws and regulations applicable to its business model; risks related to its indebtedness; changes in market or industry conditions and receptivity to its technology and services; results of litigation or a security incident; and the impact of shortages of qualified personnel and related increases in its labor costs. For a detailed discussion of the risk factors that could affect the Company's actual results, please refer to the risk factors identified in its Annual Report on Form 10-K for the year ended December 31, 2024, and the other periodic reports it files with the SEC. All information provided in this Current Report on Form 8-K is as of the date hereof, and the Company undertakes no duty to update or revise this information unless required by law.

~~The~~(d) information in this Item 7.01 of this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such a filing.Exhibits

Exhibit Number		Description

99.1		Press Release dated October 30, 2025
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Alignment Healthcare, Inc.		~~Alignment Healthcare, Inc.~~
Date: September 9, 2025			By:	/s/ Christopher Joyce
Date: October 30, 2025	By:	/s/ James M. Head
				Christopher Joyce
		James M. Head
				Chief Legal & Administrative Officer
		Chief Financial Officer

Filing Compare · Alignment Healthcare, Inc.